Nervous System News and Research

Latest Nervous System News and Research

Study: Brain cell death may trigger multiple sclerosis

Multiple sclerosis (MS) may be triggered by the death of brain cells that make myelin, the insulation around nerve fibers, according to research on a novel mouse model developed by scientists from the University of Chicago and Northwestern Medicine. The death of these cells initiates an autoimmune response against myelin, the main characteristic of the disease, which leads to MS-like symptoms in mice.

14 Dec 2015

Egalet, Teva sign agreement to commercialize SPRIX Nasal Spray in Israel, Gaza and the West Bank

Egalet Corporation, a fully integrated specialty pharmaceutical company focused on developing, manufacturing and commercializing innovative treatments for pain and other conditions, today announced a collaboration agreement with Teva Pharmaceutical Industries Ltd., a leading global pharmaceutical company.

14 Dec 2015

Report uncovers how Down syndrome hampers nervous system that plays key role in health, longevity

While most Down syndrome research has focused on the brain, a new report by Johns Hopkins University biologists uncovers how the disorder hampers a separate part of the nervous system that plays a key role in health and longevity.

14 Dec 2015

Designing epidemiologic study for multiple sclerosis and other neurologic diseases in Gulf War Vets

The U.S. Department of Veterans Affairs requested that the National Academies of Sciences, Engineering, and Medicine conduct a study to respond to Public Law 110-389 to determine the incidence, prevalence, and risk of developing multiple sclerosis and other neurologic diseases -- including migraines, Parkinson's disease, brain cancers, and central nervous system abnormalities difficult to diagnose precisely -- as a result of service in the 1990-1991 Persian Gulf and post 9/11 Global Operations theaters.

12 Dec 2015

Sex differences in the brain may provide clues to why certain forms of autism more common in males

Many early-onset neurodevelopmental disorders, including autism spectrum disorders, are more common in males than females. The origin of this gender bias is not understood, partially due to a major gap in research on sex differences regarding how the brain typically develops.

11 Dec 2015

Single dose of psilocybin decreases anxiety, depression in cancer patients

A single dose of psilocybin, the major hallucinogenic component in magic mushrooms, induces long-lasting decreases in anxiety and depression in patients diagnosed with life-threatening cancer according to a new study presented today at the annual meeting of the American College of Neuropsychopharmacology.

11 Dec 2015

Report shows relationship between sensation seeking, reward sensitivity and cannabis use

Sensation seeking is a personality trait that describes a person's tendency to seek out novel and exciting experiences, and a high level of sensation seeking has been implicated as a risk factor for addiction.

11 Dec 2015

Apigenin improves neuron formation, strengthens connections between brain cells

Brazilian researchers from D'Or Institute for Research and Education, Federal University of Rio de Janeiro and Federal University of Bahia have demonstrated in laboratory that apigenin, a substance found in parsley, thyme, chamomile and red pepper, improves neuron formation and strengthens the connections between brain cells.

11 Dec 2015

LSD reduces connectivity within human brain networks

LSD is known to cause changes in consciousness, including "ego-dissolution", or a loss of the sense of self. Despite a detailed knowledge of the action of LSD at specific serotonin receptors, it has not been understood how this these pharmacological effects can translate into such a profound effect on consciousness.

11 Dec 2015

Neuroscientists find link between neurotransmitter GABA and tactile learning

In an international collaboration with the Johns Hopkins University (Baltimore, MD, USA), neuroscientists at the Ruhr-University Bochum have determined a link between brain levels of the neurotransmitter GABA, the main source of inhibition in the brain, and tactile learning. Using magnetic resonance spectroscopy, they were able to show that success in learning can be predicted by baseline GABA levels.

11 Dec 2015

Circuit awarded contract to pursue optogenetic therapies for peripheral nervous system indications

Circuit Therapeutics today announced that it has been awarded a 2.7 million dollar contract from the Defense Advanced Research Projects Agency to pursue optogenetic therapies for peripheral nervous system indications. The award, part of DARPA's Electrical Prescriptions (ElectRX) program, will enable Circuit to pursue research and development projects related to its treatment for neuropathic pain.

10 Dec 2015

New heart failure drug may increase patients' risk of Alzheimer's disease, macular degeneration

Patients with mild heart failure stand to benefit from a new drug that can halt the progression of their disease and reduce their risk of cardiovascular-related death. But the drug -- a tablet that combines the agents valsartan and sacubitril, sold under the trade name Entresto by drugmaker Novartis -- may be too good to be true, according to Arthur M. Feldman, MD, PhD, Executive Dean of the Lewis Katz School of Medicine at Temple University, Chief Academic Officer of the Temple University Health System, and Laura H. Carnell Professor of Medicine at LKSOM.

10 Dec 2015

Surgery and manual physical therapies similarly effective in improving pain for CTS patients

Results of a randomized clinical trial, published in The Journal of Pain, showed that surgery and manual physical therapies were similarly effective in improving pain and function for patients with carpal tunnel syndrome (CTS).

9 Dec 2015

Bionomics plans to launch BNC210 Phase 2 trial for treatment of PTSD

Australian drug development company Bionomics Limited will launch a key Phase 2 trial of its novel anxiety drug BNC210 as a treatment for post-traumatic stress disorder (PTSD), following a US$12 million private placement to US institutional investors.

8 Dec 2015

Children born to mothers with PCOS at increased risk of developing autism

Children born to mothers with polycystic ovarian syndrome, PCOS, are at an increased risk of developing autism spectrum disorders, according to a new epidemiological study from Sweden's Karolinska Institutet. The findings, which are published in the journal Molecular Psychiatry, support the notion that exposure to sex hormones early in life may be important for the development of autism in both sexes.

8 Dec 2015

New algorithm helps analyze microscope images of cells growing in petri dishes

Scientists looking for ways to stimulate the growth of neurons can spend hours painstakingly analyzing microscope images of cells growing in petri dishes. A new algorithm developed by Brown University researchers automates that process and analyzes images more accurately than previous automated approaches.

8 Dec 2015

Existing compound offers hope for slowing Huntington's disease progression

Currently, there is no treatment to halt the progression of Huntington's disease (HD), a fatal genetic disorder that slowly robs sufferers of their physical and mental abilities. Now, researchers at University of California, San Diego School of Medicine have discovered that an existing compound, previously tested for diabetes, offers hope for slowing HD and its symptoms.

8 Dec 2015

Pediatric chemotherapy regimen improves outcomes in young adults with ALL

Using a pediatric chemotherapy regimen to treat young adults with acute lymphoblastic leukemia (ALL) significantly improved their outcomes compared to what has historically been achieved with 'adult' treatment protocols, report Dana-Farber Cancer Institute scientists.

8 Dec 2015

Children suffering from neuroblastoma may benefit from potential new treatment

Children suffering from a cancer of the nervous system could benefit from a potential new treatment, thanks to an international team led by researchers at the University of Kent and at the Institute of Medical Virology at the Goethe-University, Frankfurt am Main, Germany.

7 Dec 2015

Taking estriol along with conventional medications helps RRMS patients avoid relapses

Taking the pregnancy hormone estriol along with their conventional medications helped patients with relapsing-remitting multiple sclerosis (RRMS) avoid relapses, according to results of a Phase II randomized, placebo-controlled study led by UCLA researchers.

1 Dec 2015

Nervous System News and Research

Latest Nervous System News and Research

Study: Brain cell death may trigger multiple sclerosis

Egalet, Teva sign agreement to commercialize SPRIX Nasal Spray in Israel, Gaza and the West Bank

Report uncovers how Down syndrome hampers nervous system that plays key role in health, longevity

Designing epidemiologic study for multiple sclerosis and other neurologic diseases in Gulf War Vets

Sex differences in the brain may provide clues to why certain forms of autism more common in males

Single dose of psilocybin decreases anxiety, depression in cancer patients

Report shows relationship between sensation seeking, reward sensitivity and cannabis use

Apigenin improves neuron formation, strengthens connections between brain cells

LSD reduces connectivity within human brain networks

Neuroscientists find link between neurotransmitter GABA and tactile learning

Circuit awarded contract to pursue optogenetic therapies for peripheral nervous system indications

New heart failure drug may increase patients' risk of Alzheimer's disease, macular degeneration

Surgery and manual physical therapies similarly effective in improving pain for CTS patients

Bionomics plans to launch BNC210 Phase 2 trial for treatment of PTSD

Children born to mothers with PCOS at increased risk of developing autism

New algorithm helps analyze microscope images of cells growing in petri dishes

Existing compound offers hope for slowing Huntington's disease progression

Pediatric chemotherapy regimen improves outcomes in young adults with ALL

Children suffering from neuroblastoma may benefit from potential new treatment

Taking estriol along with conventional medications helps RRMS patients avoid relapses

Everything you need to know about epilepsy eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Nervous System News and Research

Latest Nervous System News and Research

Everything you need to know about epilepsy eBook

CellVoyant's AI-Powered Vision for the Future of Cell Therapy

Scalable, Smart, and Accessible: The Future of Lab Automation

Healthy Beginnings, Hopeful Futures: A Conversation with WHO’s Dr. Allotey

Newsletters you may be interested in